Specific Cancer Biomarkers—Detection of Prostate Cancer Associated 3 (PCA3) [69] in urine offers a non-invasive method for prostate cancer screening, potentially appearing earlier than traditional markers like prostate-specific antigen (PSA). This evidence concerns the gene KLK3 and prostate carcinoma.